Sign In
Buy INSP
$40.47
-0.110 (-0.271%)
At Close: Jun 03, 2026
Inspire Medical Systems, Inc. to Report Third Quarter 2023 Financial Results on November 7, 2023
08:00am, Tuesday, 03'rd Oct 2023
MINNEAPOLIS, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2023 after the close of trading on Tuesday, Nov
Here's Why You Should Retain Inspire Medical (INSP) Stock Now
12:46pm, Tuesday, 26'th Sep 2023
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2023 Healthcare Conference
08:00am, Wednesday, 23'rd Aug 2023
MINNEAPOLIS, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima
Inspire Medical Systems: Excellent Execution And Reset Valuation
08:31pm, Wednesday, 16'th Aug 2023
Inspire Medical Systems has performed well in 2023 with its hyperglossal nerve stimulation design for sleep apnea sufferers. The company plans to release a version without a sensor lead in 2024, makin
Inspire Medical (INSP) Q2 Earnings & Revenues Top Estimates
12:42pm, Wednesday, 02'nd Aug 2023
Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the second quarter.
Inspire Medical Systems, Inc. (INSP) Q2 2023 Earnings Call Transcript
01:04am, Wednesday, 02'nd Aug 2023
Inspire Medical Systems, Inc. (NYSE:INSP ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & C
Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics
08:56pm, Tuesday, 01'st Aug 2023
While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to
Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates
06:40pm, Tuesday, 01'st Aug 2023
Inspire Medical Systems (INSP) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $0.53 per share a year ago.
Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment
02:17pm, Wednesday, 19'th Jul 2023
Inspire Medical Systems has reported a significant 84% rise in Q1 2023 revenue, reaching $127.9 million, driven by its innovative treatments for Obstructive Sleep Apnea. The company has received FDA c
Inspire Medical Up 15% After Breakout, Analysts Say It's A Buy
08:26am, Thursday, 06'th Jul 2023
Inspire Medical Systems NYSE: INSP is up nearly 15% since breaking out of cup-with-handle base on May 3. The base's buy point was above $277.18, which you can see on the Inspire Medical Systems chart.
Inspire Medical Systems, Inc. to Report Second Quarter 2023 Financial Results on August 1, 2023
08:00am, Wednesday, 05'th Jul 2023
MINNEAPOLIS, July 05, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2023 after the close of trading on Tuesday, Au
Inspire Medical (INSP) Hits 52-Week High: What's Aiding It?
12:01pm, Monday, 26'th Jun 2023
Investors are optimistic about Inspire Medical's (INSP) global presence.
7 Healthcare Stocks to Make You the Millionaire Next Door
08:41pm, Wednesday, 21'st Jun 2023
Investing in healthcare stocks can be a wise decision for those looking to become wealthy in the long term. Some of the best healthcare stocks to buy are firms that are developing highly effective dr
Inspire Medical Systems: Valuation, Sentiment, Fundamental Factors Call For Re-Rating
10:30pm, Wednesday, 14'th Jun 2023
Inspire Medical has multiple catalysts in the pipeline that could see it attract investment. These center around fundamental, sentimental and valuation factors. The company could be fairly valued at $
Inspire (INSP) Gets FDA Nod for Expanded Indication of AHI
10:28am, Monday, 12'th Jun 2023
The FDA approves Inspire's (INSP) application to expand the indication to include patients with AHI up to 100 events per hour.
